Literature DB >> 25199496

Multicenter, randomized trial comparing native vaginal tissue repair and synthetic mesh repair for genital prolapse surgical treatment.

Simone Dos Reis Brandão da Silveira1, Jorge Milhem Haddad, Zsuzsanna Ilona Katalin de Jármy-Di Bella, Fernanda Nastri, Miriam Goncalves Markos Kawabata, Silvia da Silva Carramão, Claudinei Alves Rodrigues, Edmund Chada Baracat, Antonio Pedro Flores Auge.   

Abstract

INTRODUCTION AND HYPOTHESIS: This trial aimed to compare the outcomes of native vaginal tissue repair versus polypropylene mesh repair for the treatment of severe genital prolapse.
METHODS: This multicenter randomized trial included 184 women, with POP-Q stage 3 or 4. They were randomly assigned to undergo surgical treatment using native tissue repair (n = 90) or synthetic mesh repair (n = 94). Native tissue repair surgery was performed according to site-specific defects, including sacrospinous ligament fixation for apical defects. Mesh repair (Prolift™) was performed in accordance with manufacturer recommendations. Hysterectomy was performed in all cases of uterine prolapse. Statistical tests were used to compare between-group and within-group differences before the surgery and at 1-year follow-up. We considered cure to have occurred when the POP-Q point evaluation was equal to or less than 0 and POP-Q point C better than or equal to half the total vaginal length (TVL) after 1 year. The patients answered the Prolapse Quality-of-Life Questionnaire (PQoL) and the Sexual Quotient Female Version (QS-F) questionnaire.
RESULTS: Both groups were homogeneous preoperatively. There were no differences between the groups in operative time, complications or pain. At 1-year follow-up, anatomical cure rates were better in the mesh group in the anterior compartment (p = 0.019). Significant improvement in PQoL scores at 1-year follow up were observed in each group; between-group comparisons of changes in PQoL scores revealed greater improvement in the mesh group.
CONCLUSION: Both techniques were effective. Anatomical efficacy was superior in the mesh group regarding the anterior compartment; quality of life changes were also greater in the mesh group. Complications were significantly higher in the mesh group.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25199496     DOI: 10.1007/s00192-014-2501-z

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  25 in total

1.  Anterior vaginal wall prolapse: a randomized controlled trial of SIS graft versus traditional colporrhaphy.

Authors:  Paulo Cezar Feldner; Rodrigo Aquino Castro; Luiz Antonio Cipolotti; Carlos Antonio Delroy; Marair Gracio Ferreira Sartori; Manoel João Batista Castello Girão
Journal:  Int Urogynecol J       Date:  2010-04-29       Impact factor: 2.894

Review 2.  Estrogens and the lower urinary tract.

Authors:  Dudley Robinson; Linda Cardozo
Journal:  Neurourol Urodyn       Date:  2011-06       Impact factor: 2.696

3.  Combined anterior trans-obturator mesh and sacrospinous ligament fixation in women with severe prolapse--a case series of 30 months follow-up.

Authors:  Tsia-Shu Lo; Kiran Ashok
Journal:  Int Urogynecol J       Date:  2010-11-04       Impact factor: 2.894

4.  Selection of patients in whom vaginal graft use may be appropriate. Consensus of the 2nd IUGA Grafts Roundtable: optimizing safety and appropriateness of graft use in transvaginal pelvic reconstructive surgery.

Authors:  G Willy Davila; Kaven Baessler; Michel Cosson; Linda Cardozo
Journal:  Int Urogynecol J       Date:  2012-03-07       Impact factor: 2.894

5.  Transvaginal polypropylene mesh versus sacrospinous ligament fixation for the treatment of uterine prolapse: 1-year follow-up of a randomized controlled trial.

Authors:  Eliana Duarte Lopes; Nucélio Luiz de Barros Moreira Lemos; Silvia da Silva Carramão; Jacqueline Leme Lunardelli; José Maria Cordeiro Ruano; Tsutomu Aoki; Antonio Pedro Flores Auge
Journal:  Int Urogynecol J       Date:  2010-04       Impact factor: 2.894

6.  Comparison of effectiveness of vaginal and abdominal routes in treating severe uterovaginal or vault prolapse.

Authors:  C C M Ng; W H C Han
Journal:  Singapore Med J       Date:  2004-10       Impact factor: 1.858

7.  Validation of the Prolapse Quality-of-Life Questionnaire (P-QoL) in Portuguese version in Brazilian women.

Authors:  Márcia Silva de Oliveira; José Tadeu Nunes Tamanini; Geraldo de Aguiar Cavalcanti
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-07-04

8.  Safety of Trans Vaginal Mesh procedure: retrospective study of 684 patients.

Authors:  Fréderic Caquant; Pierre Collinet; Philippe Debodinance; Juan Berrocal; Olivier Garbin; Claude Rosenthal; Henri Clave; Richard Villet; Bernard Jacquetin; Michel Cosson
Journal:  J Obstet Gynaecol Res       Date:  2008-08       Impact factor: 1.730

Review 9.  What's new in prolapse surgery?

Authors:  Bruno Deval; François Haab
Journal:  Curr Opin Urol       Date:  2003-07       Impact factor: 2.309

10.  Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort.

Authors:  Guri Rortveit; Jeanette S Brown; David H Thom; Stephen K Van Den Eeden; Jennifer M Creasman; Leslee L Subak
Journal:  Obstet Gynecol       Date:  2007-06       Impact factor: 7.661

View more
  9 in total

1.  Utero-vaginal suspension using bilateral vaginal anterior sacrospinous fixation with mesh: intermediate results of a cohort study.

Authors:  Vincent Letouzey; Daniela Ulrich; Eva Balenbois; Arnaud Cornille; Renaud de Tayrac; Brigitte Fatton
Journal:  Int Urogynecol J       Date:  2015-05-31       Impact factor: 2.894

2.  Native-tissue repair of isolated primary rectocele compared with nonabsorbable mesh: patient-reported outcomes.

Authors:  Lene Duch Madsen; Emil Nüssler; Ulrik Schiøler Kesmodel; Susanne Greisen; Karl Møller Bek; Marianne Glavind-Kristensen
Journal:  Int Urogynecol J       Date:  2016-07-05       Impact factor: 2.894

3.  Modified McCall culdoplasty versus Shull suspension in pelvic prolapse primary repair: a retrospective study.

Authors:  Federico Spelzini; Matteo Frigerio; Stefano Manodoro; Maria Lieta Interdonato; Maria Cristina Cesana; Debora Verri; Caterina Fumagalli; Martina Sicuri; Elena Nicoli; Serena Polizzi; Rodolfo Milani
Journal:  Int Urogynecol J       Date:  2016-04-05       Impact factor: 2.894

Review 4.  Current surgical management of pelvic organ prolapse: Strategies for the improvement of surgical outcomes.

Authors:  Kwang Jin Ko; Kyu-Sung Lee
Journal:  Investig Clin Urol       Date:  2019-10-29

5.  Outcomes of vaginal hysterectomy combined with anterior and posterior colporrhaphy for pelvic organ prolapse: a single center retrospective study.

Authors:  Ju Hee Kim; So Young Lee; Hee Dong Chae; Yoon Kyung Shin; Sa Ra Lee; Sung Hoon Kim
Journal:  Obstet Gynecol Sci       Date:  2021-11-05

Review 6.  Surgery for women with apical vaginal prolapse.

Authors:  Christopher Maher; Benjamin Feiner; Kaven Baessler; Corina Christmann-Schmid; Nir Haya; Julie Brown
Journal:  Cochrane Database Syst Rev       Date:  2016-10-01

Review 7.  Reasons for and Against Use of Non-absorbable, Synthetic Mesh During Pelvic Organ Prolapse Repair, According to the Prolapsed Compartment.

Authors:  Stavros Kontogiannis; Evangelia Goulimi; Konstantinos Giannitsas
Journal:  Adv Ther       Date:  2016-10-18       Impact factor: 3.845

8.  Anterior colporrhaphy: a standard operation? Systematic review of the technical aspects of a common procedure in randomized controlled trials.

Authors:  Ksenia Halpern-Elenskaia; Wolfgang Umek; Barbara Bodner-Adler; Engelbert Hanzal
Journal:  Int Urogynecol J       Date:  2017-12-06       Impact factor: 2.894

9.  A systematic review of outcome and outcome-measure reporting in randomised trials evaluating surgical interventions for anterior-compartment vaginal prolapse: a call to action to develop a core outcome set.

Authors:  Constantin M Durnea; Vasilios Pergialiotis; James M N Duffy; Lina Bergstrom; Abdullatif Elfituri; Stergios K Doumouchtsis
Journal:  Int Urogynecol J       Date:  2018-10-22       Impact factor: 2.894

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.